CAPNS1 and breast carcinoma: Reduced p-S9-GSK-3β levels in capns1 KO tumors is consistent with previous observations of reduced AKT activation in capns1 KO MEF cells [11], and increased PP2A levels in capn2 knockdown mammary carcinoma cells [9] and capns1 KO MEFs [49].